2022-08-20 高雄萬豪酒店 10F皇喜會議室 10D-1
| 時間 | 主題 | 講者 | 座長 | 摘要 | 簡報 |
|---|---|---|---|---|---|
09:00 ~ 09:10 |
PD01-1: A genome-wide association study (GWAS) of kidney stone disease in the Taiwanese population. |
李明儒 |
周詠欽, 林承家 |
||
09:10 ~ 09:20 |
PD01-2: The sodium-glucose cotransporter-2 inhibitor dapagliflozin inhibit kidney stone formation through modulating AMPK-mediated autophagy |
劉展榮 |
周詠欽, 林承家 |
||
09:20 ~ 09:30 |
PD01-3: Urine NT-probnp as a non-invasive indicator for recovery of renal function after receiving ureteroscopic surgery aiming at relieving hydronephrosis |
劉佳旻 |
周詠欽, 林承家 |
||
09:30 ~ 09:40 |
PD01-4: Comparison of surgical outcomes between ultramini-endoscopic combined intrarenal surgery and retrograde intrarenal surgery |
潘思穎 |
周詠欽, 林承家 |
||
09:40 ~ 09:50 |
PD01-5: Comparative analysis of simultaneous supine percutaneous nephrolithotomy with ureteroscopic lithotripsy and retrograde intrarenal surgery in the management of large proximal ureteral calculi |
林崇裕 |
周詠欽, 林承家 |
||
09:50 ~ 10:00 |
PD01-6: Comparison of mini endoscopic combined intrarenal surgery and multitract percutaneous nephrolithotomy specifically for kidney staghorn stones: A single-center experience |
陳致豪 |
周詠欽, 林承家 |